267 related articles for article (PubMed ID: 32350869)
1. Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
Allergy; 2020 Oct; 75(10):2623-2632. PubMed ID: 32350869
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life of Food-Allergic Patients Before, During, and After Oral Immunotherapy.
Epstein-Rigbi N; Goldberg MR; Levy MB; Nachshon L; Elizur A
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):429-436.e2. PubMed ID: 30129441
[TBL] [Abstract][Full Text] [Related]
3. Changes in patient quality of life during oral immunotherapy for food allergy.
Rigbi NE; Goldberg MR; Levy MB; Nachshon L; Golobov K; Elizur A
Allergy; 2017 Dec; 72(12):1883-1890. PubMed ID: 28542911
[TBL] [Abstract][Full Text] [Related]
4. Medical clown support is associated with better quality of life of children with food allergy starting oral immunotherapy.
Epstein Rigbi N; Schwartz N; Goldberg MR; Levy MB; Nachshon L; Elizur A
Pediatr Allergy Immunol; 2021 Jul; 32(5):1029-1037. PubMed ID: 33452829
[TBL] [Abstract][Full Text] [Related]
5. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
[TBL] [Abstract][Full Text] [Related]
6. Patient quality of life following induction of oral immunotherapy for food allergy.
Epstein Rigbi N; Katz Y; Goldberg MR; Levy MB; Nachshon L; Elizur A
Pediatr Allergy Immunol; 2016 May; 27(3):263-8. PubMed ID: 26681071
[TBL] [Abstract][Full Text] [Related]
7. Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies.
DunnGalvin A; Fleischer DM; Campbell DE; O'B Hourihane J; Green TD; Sampson HA; Greenhawt M
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):216-224.e1. PubMed ID: 32841748
[TBL] [Abstract][Full Text] [Related]
8. Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy.
Shin S; Jang S; Kim J; Song J; Park S; Kim Y; Lee MH; Kim HM; Choi YR; Jung M; Kim M; Lee JY; Baek J; Kim S; Kim J; Ahn K
Allergy Asthma Proc; 2024 Mar; 45(2):128-136. PubMed ID: 38449018
[No Abstract] [Full Text] [Related]
9. Parents report better health-related quality of life for their food-allergic children than children themselves.
van der Velde JL; Flokstra-de Blok BM; Dunngalvin A; Hourihane JO; Duiverman EJ; Dubois AE
Clin Exp Allergy; 2011 Oct; 41(10):1431-9. PubMed ID: 21569128
[TBL] [Abstract][Full Text] [Related]
10. Development of an Oral Immunotherapy-Related Parental Burden Scale.
Maeta A; Takaoka Y; Hamada M; Nakano A; Sumimoto S; Anzai K; Tanaka Y; Morikawa S; Kameda M; Takahashi K
Int Arch Allergy Immunol; 2023; 184(12):1203-1215. PubMed ID: 37647864
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of food allergy oral immunotherapy in adults.
Epstein-Rigbi N; Levy MB; Nachshon L; Koren Y; Katz Y; Goldberg MR; Elizur A
Allergy; 2023 Mar; 78(3):803-811. PubMed ID: 36190349
[TBL] [Abstract][Full Text] [Related]
12. Parent perceived quality of life is age-dependent in children with food allergy.
Wassenberg J; Cochard MM; Dunngalvin A; Ballabeni P; Flokstra-de Blok BM; Newman CJ; Hofer M; Eigenmann PA
Pediatr Allergy Immunol; 2012 Aug; 23(5):412-9. PubMed ID: 22554401
[TBL] [Abstract][Full Text] [Related]
13. Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity.
DunnGalvin A; de BlokFlokstra BM; Burks AW; Dubois AE; Hourihane JO
Clin Exp Allergy; 2008 Jun; 38(6):977-86. PubMed ID: 18435800
[TBL] [Abstract][Full Text] [Related]
14. Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy.
Nachshon L; Schwartz N; Tsviban L; Levy MB; Goldberg MR; Epstein-Rigby N; Katz Y; Elizur A
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):185-192.e3. PubMed ID: 32750430
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy.
Blumchen K; Trendelenburg V; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Holzhauser T; Roeder M; Rosenfeld L; Hartmann O; Niggemann B; Beyer K
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):479-491.e10. PubMed ID: 30423449
[TBL] [Abstract][Full Text] [Related]
16. Oral immunotherapy for peanut allergy: The pro argument.
Chinthrajah RS; Cao S; Dunham T; Sampath V; Chandra S; Chen M; Sindher S; Nadeau K
World Allergy Organ J; 2020 Aug; 13(8):100455. PubMed ID: 33005286
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of patients diagnosed as non-allergic following food allergy oral immunotherapy referral.
Koren Y; Nachshon L; Goldberg MR; Levy MB; Epstein-Rigbi N; Elizur A
Pediatr Res; 2023 Feb; 93(3):643-648. PubMed ID: 35641552
[TBL] [Abstract][Full Text] [Related]
18. Quality of life associated with maternal anxiety disorder in Russian children and adolescents with food allergy.
DunnGalvin A; Treneva M; Pampura A; Grebenko A; Makatsori M; Munblit D
Pediatr Allergy Immunol; 2020 Jan; 31(1):78-84. PubMed ID: 31562786
[TBL] [Abstract][Full Text] [Related]
19. Validation and reliability of the Japanese version of the Food Allergy Quality of Life Questionnaire-Parent Form.
Mizuno Y; Ohya Y; Nagao M; DunnGalvin A; Fujisawa T
Allergol Int; 2017 Apr; 66(2):290-295. PubMed ID: 27599914
[TBL] [Abstract][Full Text] [Related]
20. Oral immunotherapy for multiple foods in a pediatric allergy clinic setting.
Eapen AA; Lavery WJ; Siddiqui JS; Lierl MB
Ann Allergy Asthma Immunol; 2019 Dec; 123(6):573-581.e3. PubMed ID: 31494236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
